MedTrace Logo

A Herbal Compound for Eczema

NCT06758752 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2025-01-06

No results posted yet for this study

Summary

The goal of this interventional clinical trial study is to compare ZAX.1400.EC.02 and placebo in Eczema patients. The main question it aims to answer is:

• Can treatment with ZAX.1400.EC.02 for 3 weeks improve clinical signs of skin in Eczema patients? Participants will be divided into two groups. One group will use ZAX.1400.EC.02 topically twice daily for 3 weeks and the other group will use placebo topically twice daily for 3 weeks.

Researchers will compare treatment and placebo groups to see if there is any improvement in the clinical signs of skin caused by Eczema after treatment with ZAX.1400.EC.02 for 3 weeks.

Conditions

Interventions

DIETARY_SUPPLEMENT

ZAX.1400.EC.02

ZAX.1400.EC.02, applied twice daily for 3 weeks after enrolment

DRUG

Placebo

Placebo, applied twice daily for 3 weeks after enrolment

Sponsors & Collaborators

  • Herbmedx Co

    collaborator INDUSTRY

  • Zarrin Avaye Kowsar Salamat (ZAX company)

    collaborator UNKNOWN

  • Fasa University of Medical Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2026-12-30
Completion
2026-12-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06758752 on ClinicalTrials.gov